May 18, 2022, 09:21 AM by

Through years of dedicated efforts, Alfa Chemistry has become one of the most popular suppliers of analytical reagents among customers across the globe. Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research.

May 18, 2022, 01:00 AM by User Not Found

Bio-IT World | A meta-analysis of new and previous genome-wide association studies (GWAS) has identified 75 genetic risk factors for Alzheimer’s disease (AD), 42 of which weren’t previously implicated. The investigation confirms the importance of two pathological brain phenomena that are currently pursued therapeutic targets and strengthens the case for having microglial cells join the hit list, according to Jean-Charles Lambert, research director at Inserm (National Institute of Health and Medical Research) based in Lille, France.

May 17, 2022, 15:46 PM by

BRIM Biotechnology, Inc. (“BRIM”), a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”), the world’s leading ophthalmic research organization for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora’s support later this year.

May 17, 2022, 15:46 PM by

May 17, 2022, 15:46 PM by

May 17, 2022, 15:46 PM by

May 17, 2022, 15:46 PM by

New VIDA analysis packages & novel biomarkers empower trial sponsors to unlock breakthrough insights

May 17, 2022, 15:46 PM by

May 17, 2022, 15:46 PM by

BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.

May 17, 2022, 15:46 PM by

BOC Sciences has prepared a long list of first-rate pseudoUridines to be presented at two industry-renowned exhibitions—CPhI North America and TIDES USA 2022. With only a few days away, BOC Sciences sincerely invites all researchers concerned to pay a visit to its booths and have a constructive conversation with its knowledgeable experts.

May 17, 2022, 15:46 PM by

BOC Sciences provides high-quality antibiotics, bioactive by-products, enzyme inhibitors, mycotoxins, and other fermented products as well as comprehensive CDMO services.

May 17, 2022, 15:46 PM by

ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment As a part of the LifeSphere® platform, this solution will be named LifeSphere Clarity and will unlock crucial data patterns leveraging machine learning Rapid, robust benefit-risk assessment is key for all organizations collecting and processing large safety data sets Intelligent tool will drive industry-wide advancement of pharmacovigilance and patient safety capabilities

May 17, 2022, 15:46 PM by

The American College of Cardiology (ACC) is leveraging Biofourmis’ AI-based predictive analytics platform and virtual health navigators for ACC’s TRANSFORM(3) study. The study—which focuses on underserved populations with a history of healthcare disparities—will evaluate different intervention strategies for improving adherence to guideline-directed medication therapy (GDMT) for managing specific chronic cardiovascular conditions.

May 17, 2022, 15:46 PM by

SeekGene, a biotechnology research firm focusing on single-cell technology, has significantly reduced processing time and cost for data intensive single-cell analysis tasks using MemVerge Memory Machine running on AliCloud i4p compute instances. As a result, SeekGene is able to cut analytical time and costs significantly while optimizing their single-cell sequencing capabilities for researchers worldwide to promote faster development of precision medicine.

May 17, 2022, 15:46 PM by

May 17, 2022, 15:46 PM by

Please find below the latest news story from Emmes (CRO) announcing the launch of its Advanatge eClinical as a standalone cloud native clinical technology platform – after more than two years in development. Unusually, the new platform will be available to both Emmes and non-Emmes customers and aims to increase access to a suitable platform particularly for smaller biotechs. Should you have any questions or would like to run a Q&A around this news, please do let me know.

May 17, 2022, 15:46 PM by

Biolog has appointed a new leadership team and secured a major investment to help drive widespread adoption of its industry-leading microbial identification and phenotypic profiling products

May 17, 2022, 15:46 PM by

Domainex Ltd, a leading integrated medicines research services partner, is pleased to announce that Dr Scott Martin has been appointed Analytical and Bioanalytical Group Leader with immediate effect.

May 17, 2022, 15:46 PM by

Rho, a global full-service contract research organization (CRO), will showcase its expertise in pulmonary and respiratory related illnesses with attendees during the 2022 American Thoracic Society (ATS) International Conference, taking place at the Moscone Center in San Francisco, May 13-18. Rho experts will be at booth #2203 to share their knowledge of the latest advances in the rapidly evolving field of pulmonary medicine, some of which include asthma, COPD and cystic fibrosis. They will be available for one-on-one interviews during the conference with those interested in learning more about Rho’s industry developments.

May 17, 2022, 15:46 PM by